Abstract
Following mantle-field irradiation for Hodgkin's disease, patients experience a transient acute pulmonary reaction resulting in a decreased vital capacity and forced expiratory volume. This reaction begins 2-3 months after the start of therapy, reaching a maximum intensity at 4-6 months and subsiding by about 8 months. In patients with intrathoracic disease, the improvement following tumor regression may result in a net increase in pulmonary function following treatment.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
